ANVS vs VRTX: Which Stock is Better?
Side-by-side comparison of Annovis Bio Inc and Vertex Pharmaceuticals Inc in 2026
ANVS
Annovis Bio Inc
$1.76
VRTX
Vertex Pharmaceuticals Inc
$441.70
Key Metrics Comparison
| Metric | ANVS | VRTX | Winner |
|---|---|---|---|
| Market Cap | $50.64M | $113.01B | VRTX |
| P/E Ratio | N/A | 28.98 | VRTX |
| EPS (TTM) | $N/A | $15.33 | VRTX |
| Revenue Growth | 0.0% | 0.1% | VRTX |
| Gross Margin | 0.0% | 53.7% | VRTX |
Analyze ANVS
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ANVS or VRTX a better investment?
Comparing ANVS and VRTX: Annovis Bio Inc has a market cap of $50.64M while Vertex Pharmaceuticals Inc has $113.01B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ANVS and VRTX?
ANVS (Annovis Bio Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ANVS or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ANVS or VRTX?
VRTX has higher revenue growth at 0.1% vs 0.0% for ANVS.
Which company is more profitable: ANVS or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to 0.0% for ANVS.
Which is the larger company: ANVS or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $113.01B compared to $50.64M for ANVS.
Should I buy ANVS or VRTX in 2026?
Both ANVS and VRTX have investment merit. ANVS trades at $1.76 while VRTX trades at $441.70. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ANVS and VRTX stock?
Key differences: Market Cap ($50.64M vs $113.01B), P/E Ratio (N/A vs 29.0x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 53.7%).